Clinical Trial Update: National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This entry covers the National Lung Matrix Trial, a multi-drug Phase II study in non-small cell lung cancer, with the trial currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Snippet

Sponsor: University of Birmingham | Conditions: Non-Small Cell Lung Cancer, Carcinoma, Squamous Cell | Phase 2 | Status: ACTIVE_NOT_RECRUITING